Cidara Thera
(CDTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,013 | -33,584 | -16,422 | -31,400 | -18,281 |
| Depreciation Amortization | 507 | 143 | 2,682 | 77 | 297 |
| Accounts receivable | -20,288 | -477 | 314 | 524 | -3,427 |
| Other Working Capital | -15,320 | 454 | 3,409 | -6,661 | -6,963 |
| Other Operating Activity | 21,190 | 4,991 | 2,546 | 2,016 | 4,766 |
| Operating Cash Flow | $-10,898 | $-28,473 | $-7,471 | $-35,444 | $-23,608 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -94 | -118 | -109 | -100 | -84 |
| Investing Cash Flow | $-94 | $-118 | $-109 | $-100 | $-84 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -2,593 | -2,593 | -2,222 | -1,111 |
| Common Stock Issued | 26,237 | 1,642 | 978 | 500 | 500 |
| Financing Cash Flow | $26,237 | $-951 | $-1,615 | $-1,722 | $-611 |
| Beginning Cash Position | 32,731 | 62,273 | 62,273 | 62,273 | 62,273 |
| End Cash Position | 47,976 | 32,731 | 53,078 | 25,007 | 37,970 |
| Net Cash Flow | $15,245 | $-29,542 | $-9,195 | $-37,266 | $-24,303 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,898 | -28,473 | -7,471 | -35,444 | -23,608 |
| Capital Expenditure | -94 | -118 | -109 | -100 | -84 |
| Free Cash Flow | -10,992 | -28,591 | -7,580 | -35,544 | -23,692 |